• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 107
  • 27
  • 6
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • Tagged with
  • 165
  • 97
  • 37
  • 30
  • 29
  • 25
  • 24
  • 23
  • 23
  • 23
  • 18
  • 18
  • 17
  • 17
  • 14
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
151

Effect of Maternal Age on Transcriptome of Granulosa Cells from Bovine Dominant Follicles

2014 January 1900 (has links)
Advanced maternal age has been shown to influence follicular and luteal dynamics in bovine ovary resulting in reduced fertility. The overall objective of the four studies presented in this thesis is to identify the maternal age-associated transcriptional changes in granulosa cells of the dominant follicles during follicle development. In the first study, mRNA expression levels of housekeeping genes were measured by real–time quantitative PCR (RT-qPCR) in granulosa cells of dominant follicles and FSH-stimulated follicles to select and validate suitable reference genes for relative gene expression analyses during maternal and follicular aging. Stability of six reference genes (GAPDH, ACTB, EIF2B2, UBE2D2, SF3A1 and RNF20) was analyzed using GeNorm, DeltaCT and NormFinder programs and comprehensive ranking order was determined based on these programs. Geometric mean of multiple genes (UBE2D2, EIF2B2, GAPDH and SF3A1) was more appropriate reference control than individual genes for the comparison of relative gene expression among dominant and FSH-stimulated follicles during maternal and/or follicular aging studies. In the second study, maternal age-associated changes in the transcriptome of granulosa cells recovered at the time of selection of the dominant follicle from aged (n=3) and young cows (n=3) were determined by EmbryoGENE bovine oligo-microarrays (EMBV3, Agilent Technology). The mRNA expression of five transcripts (CYP19A1, PCNA, GJA1, TPM2, and VNN1) was confirmed in a different set of granulosa cell samples by RT-qPCR to validate microarray data. A total of 169 genes/isoforms were differentially expressed (≥ 2-fold-change; P ≤ 0.05) in aged cows vs. young cows. These transcripts revealed inefficient 1) control of gonadotropins, and gonadotropin-induced changes in the cytoskeleton and extracellular matrix, 2) lipid metabolism and steroidogenesis 3) cell proliferation, cell cycle control and intercellular communication, and 4) higher oxidative stress responses in aged cows vs. young cows. In the third study, changes in the transcriptome of granulosa cells of the preovulatory follicle 24 h after LH treatment from aged (n= 3) and young (n=3) were determined. A total of 1340 genes were expressed differentially (≥ 2-fold change; P ≤ 0.05) in aged cows vs. young cows. The mRNA expression of five transcripts (RGS2, PTGS2, TNFAIP6, VNN1, NR5A2 and GADD45B) was confirmed in a different set of granulosa cell samples to validate microarray data. These transcripts were related to delayed 1) response to LH treatment 2) cellular differentiation and luteinization and 3) progesterone synthesis. Intra-follicle levels of progesterone were lower (P < 0.05) in aged cows compared to young and mid-aged cows. The fourth study compared the aged-associated changes in the transcriptome of granulosa cells during follicle development from the time of dominant follicle selection to preovulatory stage (24 h after LH). In comparison to young cows, aged cows expressed fewer differentially expressed genes/isoforms (1206 vs. 2260, respectively) at ≥ 2-fold-change (P ≤ 0.05) in the granulosa cells of the preovulatory (24 h after LH treatment) vs. the dominant follicle at selection. These transcripts in aged cows were related to late and inefficient 1) organization of cytoskeleton and cytoplasm, 2) differentiation, 3) lipid and cholesterol metabolism, 4) proliferation and 5) higher response to oxidative stress and free radical scavenging in the preovulatory follicles vs. the dominant follicle at selection. In conclusion, maternal age-alters the gene expression of granulosa cells of the dominant follicles during follicle development and results in a compromised follicular environment.
152

Antiosteoporotische Prinzipien in Cimicifuga racemosa BNO 1055/C001 und ihren Fraktionen / Antiosteoporotic and metabolic effects of Cimicifuga racemosa BNO 1055/C001 in bone, muscle and fat tissue

Laß, Lea 29 June 2011 (has links)
No description available.
153

Le rôle de la dysrégulation du métabolisme du cholestérol par le retrait des estrogènes sur la stéatose hépatique

Côté, Isabelle 12 1900 (has links)
Les estrogènes confèrent aux femmes une protection cardiovasculaire jusqu’à la ménopause. En effet, la perte des fonctions ovariennes engendre plusieurs désordres du profil lipidique qui s’accompagnent d’une accumulation de triglycérides au foie appelée stéatose hépatique. Le retrait des estrogènes perturbe de nombreuses voies de contrôle de la cholestérolémie, provoquant simultanément une hypercholestérolémie et une stéatose hépatiques. Toutefois, à ce jour, les mécanismes d’action du retrait des estrogènes sur le métabolisme du cholestérol favorisant le stockage de triglycérides au foie demeurent imprécis. À cet égard, les travaux de cette thèse visaient à clarifier l’ensemble des effets du retrait des estrogènes sur le métabolisme du cholestérol pouvant mener à la pathogenèse de la stéatose hépatique. Lors de la première étude, l’ovariectomie (Ovx) chez la rate, un modèle bien établi de la stéatose, avait permis d’identifier la voie d’assemblage des lipoprotéines à très faible densité (VLDL) comme élément contributif à la stéatose. La voie des VLDL reliant étant également une voie de transport du cholestérol, l’étude suivante a été réalisée afin de comprendre le rôle du cholestérol alimentaire sur les lipides hépatiques. Dans cette deuxième étude, le modèle de la diète riche en lipides et en cholestérol (HFHC), aussi reconnu pour induire une stéatose hépatique, a permis d’établir des liens étroits entre le métabolisme du cholestérol et celui des lipides hépatiques. Étonnamment, de manière similaire à l’Ovx, la diète HFHC perturbait la voie d’assemblage des VLDL. En outre, les données recueillies au cours de ces travaux indiquaient qu’une dysrégulation du métabolisme des acides biliaires avait contribué à la sévérité de la stéatose hépatique induite par cette diète HFHC. Dans la continuité de ces deux premiers projets, nous nous sommes intéressés aux effets concomitants du retrait des estrogènes et d’une diète HFHC sur la stéatose hépatique. De manière intéressante, lorsque combinés, l’Ovx et la diète HFHC potentialisaient non seulement l’accumulation de lipides hépatiques, mais également les perturbations moléculaires des voies sous-jacentes à la stéatose, dont l’assemblage des VLDL et de la sécrétion d’acides biliaires. Dans l’ensemble, les données présentées dans la revue de littérature et dans les trois études reliées à cette thèse indiquent qu’une dysrégulation du métabolisme du cholestérol en réponse au retrait des estrogènes entraîne des complications favorisant l’accumulation de lipides dans le foie. / Estrogens confer to women a cardiovascular protection until menopause. Indeed, the loss of ovarian functions leads to several lipid disorders along with hepatic triglycerides accumulation called hepatic steatosis. Estrogen withdrawal disrupts several cholesterol metabolism pathways that results in both hypercholesterolemia and hepatic steatosis. However, to date, the precise mechanisms by which estrogen withdrawal affect cholesterol metabolism pathways that favour lipid storage in the liver are unclear. In this regard, works in the present thesis aimed at elucidate the effects of estrogen withdrawal on cholesterol metabolism involved in hepatic steatosis pathogenesis. In the first study, estrogen withdrawal by ovariectomy (Ovx), a well established model for hepatic steatosis and hypercholesterolemia, had enabled the identification of very low density lipoprotein (VLDL) pathway as a contributory element for hepatic steatosis. Since the VLDL pathway relates lipids and cholesterol metabolism, we conducted the second study to explore the role of dietary cholesterol on hepatic lipids. In the second study, the high fat/high cholesterol (HFHC) diet, also recognized as a model for hepatic steatosis development, was used to explore links between cholesterol metabolism and hepatic fat accumulation. Surprisingly, HFHC diet also disrupted the VLDL pathway. Additionally, data provided in this study indicated that a dysregulation of bile acids metabolism might have contributed to the severity of hepatic steatosis induced by the HFHC diet. As a continuation of these projects, we were interested in the concomitant effects of estrogen withdrawal and HFHC diet on hepatic lipid accretion. Interestingly, when combined, Ovx and HFHC diet not only potentiated hepatic lipid accumulation but also molecular disruptions involved in underlying pathways for hepatic steatosis including the VLDL pathway and bile acid secretion. Overall, data presented in the review of litterature and provided by the three studies related to the present thesis indicate that cholesterol metabolism dysregulation following estrogen withdrawal result in complications that favour hepatic lipid accumulation.
154

Carence en œstrogènes et bases moléculaires du métabolisme des triglycérides et du cholestérol dans le foie et l'intestin : effet de l'exercice physique

Ngo Sock, Emilienne Tudor 12 1900 (has links)
La stéatose hépatique et la détérioration du profil lipidique plasmatique sont des pathologies métaboliques favorisées par la carence œstrogénique post-ménopausique. Cependant les mécanismes à la base de ces pathologies n’ont été que très peu étudiés. Le but de cette thèse a été d’investiguer les mécanismes moléculaires possibles à l’origine de l’hypercholestérolémie et de l’accumulation des lipides (triglycérides : TG et cholestérol) dans le foie en utilisant un modèle animal de la ménopause, la rate Sprague Dawley ovariectomisée (Ovx). Nous avons également examiné si le changement des habitudes de vie comme la pratique de l’exercice physique pouvait prévenir ou corriger les modifications induites par l’Ovx. Enfin, rosuvastatine (statine) a été utilisée comme thérapie pharmacologique de l’hypercholestérolémie dans le but de comprendre son effet au niveau moléculaire chez la rate Ovx. L’objectif de la première étude était de déterminer comment l’Ovx peut affecter les niveaux de TG et de cholestérol dans le foie des rates nourries avec une diète riche en lipides (HF : 42% gras). Les rates ont été soumises à la diète HF ou normale pendant 6 semaines avant d’être Ovx ou Sham (ovariectomie simulée), puis maintenues aux mêmes conditions diététiques pour 6 autres semaines. L’Ovx a provoqué une accumulation de TG dans le foie, mais pas la diète HF seule. Cependant, lorsque l’Ovx était combinée à la diète HF, l’accumulation des TG était beaucoup plus importante comparé à ce qui était observé chez les rates Ovx soumises à la diète normale. L’expression génique (ARNm) de CPT1 (Carnitine palmitoyltransferase 1), PGC1α (Peroxisome proliferator-activated receptor gamma, coactivator 1) et PPARα (Peroxysome proliferetor activated receptor alpha) intervenant dans l’oxydation des acides gras dans le foie était augmentée par la diète HF (p ˂ 0.001; p ˂ 0.01; p ˂ 0.05 respectivement) ; mais atténuée (p ˂ 0.05; p ˂ 0.05; p ˂ 0.07 respectivement) lorsque les rates ont été Ovx, favorisant ainsi l’accumulation des TG dans le foie. La combinaison de la diète HF à l’Ovx a également provoqué une hypercholestérolémie et une accumulation de cholestérol dans le foie malgré la diminution de l’expression de la HMGCoA-r (3-hydroxy-3-methylglutaryl-CoA reductase), enzyme clé de la synthèse du cholestérol. Ceci était associé à l’inhibition de l’expression génique de CYP7a1 (Cytochrome P450, family 7, subfamily a, polypeptide 1), suggérant une diminution de la synthèse des acides biliaires. Ayant constaté dans la première étude que l’Ovx élevait les niveaux de cholestérol hépatique et plasmatique, nous nous sommes fixés comme objectif dans la deuxième étude d’évaluer les effets de l’Ovx sur l’expression génique des transporteurs et enzymes responsables du métabolisme du cholestérol et des acides biliaires dans le foie et l’intestin, et de vérifier si l’exercice sur tapis roulant pouvait prévenir ou corriger les changements causés par l’Ovx. L’hypercholestérolémie constatée chez les rates Ovx comparativement aux Sham était accompagnée de la diminution de l’expression génique des récepteurs des LDL (R-LDL), des résidus de lipoprotéines (LRP1), de SREBP-2 (Sterol regulatory element binding protein 2) et de PCSK9 (Proprotein convertase subtilisin/kexin type 9) dans le foie, suggérant une défaillance dans la clairance des lipoprotéines plasmatiques. L’Ovx a aussi inhibé l’expression génique de la MTP (Microsomal triglyceride transfer protein) et stimulé celle de SR-B1 (Scavenger receptor class B, member 1); mais aucun changement n’a été observé avec CYP7a1. Ces changements moléculaires pourraient par conséquent favoriser l’accumulation de cholestérol dans le foie. L’exercice physique n’a pas corrigé les modifications causées par l’Ovx sur l’expression génique de ces molécules au niveau hépatique à l’exception de SREBP-2. Par contre, au niveau intestinal (iléum), l’exercice sur tapis roulant a inhibé l’expression génique des marqueurs moléculaires intervenant dans l’absorption des acides biliaires (OSTα/β, FXR, RXRα, Fgf15) et du cholestérol (LXRα, NCP1L1) au niveau de l’iléum chez les rates Sham entraînées. Ces adaptations pourraient prévenir le développement de l’hypercholestérolémie protégeant en partie contre la survenue de l’athérosclérose. Au vue des effets délétères (hypercholestérolémie et diminution de l’expression du R-LDL, PCSK9, LRP1, SREBP-2 et HMGCOA-r dans le foie) causés par l’Ovx sur le métabolisme du cholestérol constatés dans l’étude 2, la 3ième étude a été conçue pour évaluer l’efficacité de rosuvastatine (Ros) sur l’expression génique de ces marqueurs moléculaires chez les rates Ovx sédentaires ou soumises à l’entraînement volontaire. Ros a été administrée aux rates Ovx pendant 21 jours par voie sous-cutanée à la dose de 5mg/kg/j à partir de la 9ième semaine après l’Ovx. Ros n’a pas diminué la concentration plasmatique de LDL-C et de TC chez les rates Ovx. Par contre, Ros a stimulé (P ˂ 0.05) l’expression génique de PCSK9, SREBP-2, LRP1, HMGCoA-r et ACAT2 (Acyl-CoA cholesterol acyltransferase) mais pas significativement (P = 0.3) celle du R-LDL dans le foie des rates Ovx sédentaires et entraînées. Ros n’a pas réduit la concentration plasmatique de LDL-C probablement à cause de l’induction plus importante de PCSK9 par rapport au R-LDL. Cependant, la stimulation de LRP1 par Ros protège partiellement contre la survenue des maladies cardiovasculaires. En conclusion, les études de cette thèse indiquent que la baisse du niveau des œstrogènes entraîne des changements radicaux du métabolisme hépatique des TG et du cholestérol provoqués par des altérations de l’expression des gènes clés des voies métaboliques associées. / Hepatic steatosis and plasma lipid profile deterioration are metabolic diseases favored by post-menopausal estrogen deficiency. However, mechanisms underlying these diseases have not been systematically adressed. The aim of this thesis was to investigate molecular mechanisms causing hypercholesterolemia and lipids (triglycerides: TG and cholesterol) accumulation in the liver using animal model of menopause, the ovariectomized (Ovx) Sprague Dawley rat. We also examined whether lifestyle modifications such as physical activity can prevent or correct changes induced by Ovx. Finally, rosuvastatin (statine) was used as a pharmacological therapy of hypercholesterolemia in order to understand its effect at the molecular level in Ovx rats. The first study was designed to determine how the Ovx may affect levels of TG and cholesterol in the liver of rats fed a high-fat diet (HF: 42% fat). Rats were submitted to a HF or a normal diet for 6 weeks prior to Ovx or being sham operated, and then kept on the same diets for another 6 weeks. The Ovx increased liver TG content, but not the HF diet alone. However, the combination of Ovx and HF diet resulted in a greater liver TG accumulation than that observed in Ovx submitted to normal diet. The mRNA levels of CPT-1, PGC1 and PPARα involved in liver lipid oxidation significantly increased in rats fed the HF diet (p ˂ 0.001; p ˂ 0.01; p ˂ 0.05 respectively); but this increase was substantially less if HF fed rats were Ovx (p ˂ 0.05; p ˂ 0.05; p ˂ 0.07 respectively), thus favouring TG accumulation in the liver. The combination of HF diet and Ovx also induced hypercholesterolemia and an increase in liver total cholesterol content, in spite of the reduction of liver HMGCoA-r gene expression, the key enzyme for cholesterol synthesis. This was also associated with a decrease of liver CYP7a1 gene expression, suggesting a reduction in bile acids synthesis. Having found in the first study that the Ovx increases liver and plasma cholesterol levels, we aimed in the second study at determining the effects of Ovx on gene expression of hepatic and intestinal transporters and enzymes involved in cholesterol and bile acids metabolism; and to verify whether treadmill exercise could prevent or correct changes induced by Ovx. The Ovx resulted in hypercholesterolemia associated with a reduction in gene expression of hepatic low-density lipoprotein receptor (LDL-R), lipoprotein remnants receptor (LRP1), SREBP-2 and PCSK9, suggesting a failure in the clearance of plasma lipoproteins particles. The Ovx also inhibited the expression of MTP and stimulated that of SR-B1 in the liver, but no change was observed with CYP7a1. These molecular changes might, therefore, favor cholesterol accumulation in the liver. Exercise training did not correct the deleterious effects caused by Ovx on gene expression of these molecular markers in the liver with the exception of SREBP-2. However, in the intestine (ileum) treadmill exercise reduced gene expression of molecular markers involved in the absorption of bile acids (OSTα/β, FXR, RXRα, Fgf15) and cholesterol (LXRα, NCP1L1) in Sham trained rats compared to sedentary rats. This could prevent the development of cholestasis and hypercholesterolemia protecting partially against the onset of atherosclerosis. In view of the deleterious effects (hypercholesterolemia and decreased in gene expression of LDL-R, PCSK9, LRP1, SREBP-2 and HMGCoA-r in the liver) caused by Ovx on cholesterol metabolism observed in the second study, the 3rd study was designed to test the effect of rosuvastatin (Ros) on gene expression of these molecular markers in Ovx sedentary rats or in Ovx rats submitted to voluntary training. Ros was injected to Ovx rats subcutaneously at dose of 5mg/kg/day during 21 days from the ninth week after ovariectomy. Ros failed to decrease plasma LDL-C and TC in Ovx rats. In contrast, Ros increased (P ˂ 0.05) PCSK9, SREBP-2, LRP1, HMGCoA-r and ACAT2 but not significantly (P ˂ 0.3) LDL-R mRNA in the Ovx sedentary and trained rat liver. Ros failed to decrease plasma LDL-C in Ovx rats probably because of a stronger induction of PCSK9 than LDL-R gene expression. However by increasing LRP1 expression, Ros could decrease circulating lipoprotein remnants and, therefore, protects partially against the onset of cardiovascular diseases. In conclusion, the studies of this thesis indicate that the decrease of ovarian estrogen levels causes radical changes in hepatic TG and cholesterol metabolism caused by alterations in the expression of key genes associated with metabolic pathways.
155

Efeitos do treinamento resistido sobre o metabolismo lipídico, a inflamação e a morfometria do tecido adiposo de ratas ovariectomizadas

Stotzer, Uliana Sbeguen 06 June 2013 (has links)
Made available in DSpace on 2016-06-02T19:22:09Z (GMT). No. of bitstreams: 1 5256.pdf: 6965922 bytes, checksum: 5df2e41fa93348b8ef396978016ce615 (MD5) Previous issue date: 2013-06-06 / Universidade Federal de Sao Carlos / Visceral obesity is an important risk factor cardiovascular diseases. After menopause, fat distribution shifts to visceral depots leading to lipid metabolism disorders and chronic lowgrade inflammation. Resistance training (RT) has beneficial effects in postmenopausal women, but its effectiveness in normalizing visceral adipose tissue disorders is not well understood. To address this questions adult female Sprague-Dawley rats were randomly divided into six groups (n=6 per group): sham-sedentary (SHAM), ovariectomized- sedentary (OVX), SHAM-trained (S-T), OVX-T. Sham or ovariectomy procedure was performed with 250 grams. Three weeks after the surgery, trained groups started 10 weeks of climbing in a 1.1-m vertical ladder with progressive load of 65%, 85%, 95% and 100% of rat s previous maximal overload. All animals were killed 92 days after being ovariectomized and trained animals were killed 48 hours after the last training session. Mesenteric, parametrial and subcutaneous adipose tissues were prepared for morphometric analyses in colidina and osmium tetroxide and part of mesenteric adipose tissue was stored for mRNA analyses by quantitative PCR. Resistance training prevented ovariectomy-induced higher body weight, food intake, feeding efficiency and mesenteric and subcutaneous, but not parametrial adipocyte area. In addition, RT avoided OVX-induced upregulation in the lipogenic genes PPAR-&#947;, SREBP-1c and its downstream targets SCD-1 and ACC gene expression. Further, RT increases the gene expression of mitochondrial &#946;-oxidation enzyme CPT-1 in OVX rats. RT also prevented the chronic low-grade inflammation in OVX group, demonstrated by the presence of macrophage markers (F4/80 and CD11b), increase in activated Th1 cells (IFN-&#947;) and the proinflammatory cytokines (TNF-&#945;, IL-1&#946; and IL-6). RT additionally created an antiinflammatory (IL-10) environment. The present results reflect a powerful prophylactic effects of resistance training in preventing pathological effects of estrogen deficiency, both at physiological and molecular levels. Therefore, we suggest that this may be an advantageous low cost-effective treatment at post-menopausal phase, since appropriately prescribed. / A obesidade visceral é um importante fator de risco para doenças cardiovasculares. Após a menopausa, as gorduras passam a ser depositadas preferencialmente em locais viscerais e surgem desordens no metabolismo lipídico e um quadro inflamatório crônico de baixa intensidade. O treinamento resistido (TR) possui efeitos benéficos na pós-menopausa, mas não se sabe se ele é efetivo para normalizar as desordens do tecido adiposo visceral. Para pesquisar estas respostas, ratas Sprague-Dawley adultas foram divididas em 4 grupos (n=6 por grupo): Sham sedentárias (SHAM), ovariectomizadas sedentárias (OVX), sham treinadas (SHAM-TR) e OVX-TR. A cirurgia foi realizada quando as ratas estavam com 250 gramas. Após 3 semanas, os grupos treinados iniciaram um programa de treinamento de 10 semanas (3x por semana) de escalada (4-9 repetições) em uma escada vertical de 1,1 m de altura com sobrecargas progressivas de 65%, 85%, 95% and 100% da carga máxima do rato. As ratas foram sacrificadas 92 dias após a ovariectomia e 48 horas após a última sessão de treino. Os tecidos adiposos mesentérico, parametrial e subcutâneo foram preparados em colidina e tetróxido de ósmio para análises morfométricas e parte do tecido mesentérico foi armazenado para análises de expressão gênica por PCR quantitativa. O treinamento resistido evitou o aumento de massa corporal provocado pela ovariectomia, consumo alimentar, eficiência alimentar e a área dos adipócitos mesentérico e subcutâneo, mas não do parametrial. Além disso, evitou a alta expressão dos genes lipogênicos PPAR-&#947;, SREBP-1c e de seus genes alvos ACC e SCD-1. Adicionalmente, o TR, aumentou a expressão do gene da &#946;-oxidação mitocondrial CPT-1 nas ratas OVX-TR. O TR também evitou a condição inflamatória de baixa intensidade instaurada nas ratas OVX, demonstrado pelo acúmulo de macrófagos (F4/80 e CD11b), aumento de células Th1 ativadas (IFN-&#947;) e de mediadores pó-inflamatórios (TNF-&#945;, IL-1&#946; e IL-6), além de criar um ambiente anti-inflamatório (IL-10). Os resultados deste trabalho refletem um significativo efeito profilático do treinamento resistido sobre parâmetros fisiológicos e moleculares na falta dos hormônios ovarianos. Portanto, podemos sugerir que este pode ser um vantajoso tratamento de baixo custo no período pós-menopausal, se adequadamente prescrito.
156

Influência da idade, sexo e dos hormônios gonadais na percepção dolorosa em modelo de dor neuropática em ratos / Influence of age, sex and gonadal hormones on pain perception in neuropathic pain model in rats

Claudia Carneiro de Araujo Palmeira 23 October 2014 (has links)
Os fatores idade e sexo modificam a experiência dolorosa em animais e seres humanos. Os efeitos dos hormônios gonadais têm sido estudados em diversos modelos experimentais de dor, no entanto, o efeito do envelhecimento na percepção à dor carece de mais investigação. O efeito do envelhecimento na dor neuropática ainda não está bem estabelecido. Neste estudo se procurou avaliar possíveis variações na percepção da dor da hiperalgesia mecânica, em função da idade, presença e ausência de hormônios gonadais e sexo em ratos Wistar machos e fêmeas, jovens e idosos no modelo de dor neuropática, ligadura da quinta raiz lombar. Os animais foram divididos nos seguintes grupos: ratos jovens orquiectomizados e não-orquiectomizados, ratos idosos orquiectomizados e não-orquiectomizados, ratas jovens ooforectomizadas com ou sem reposição de 17beta-estradiol e ratas idosas. Foi testado o limiar de retirada da pata após estímulo mecânico antes da ligadura e no 7º, 14º, 21º e 28o dias após a ligadura. Os resultados mostraram que todos os animais apresentaram comportamento hiperalgésico após ligadura da quinta raiz lombar durante os 28 dias de observação. A hiperalgesia ocorreu independentemente do sexo do animal, da presença ou ausência de hormônios gonadais ou idade. Não houve diferença entre ratos jovens e idosos não-orquiectomizados (p = 0,420), entre ratos jovens e idosos orquiectomizados (p = 0,560). Entre os ratos idosos com e sem orquiectomia houve diferença no 14º (p = 0,038) e 28º (p = 0,002) dias. Ratas jovens ooforectomizadas sem reposição de 17beta-estradiol apresentaram menor hiperalgesia que ratas ooforectomizadas com reposição durante todo o período (p = 0,001). Não houve diferença entre ratos idosos orquiectomizados e ratas idosas (p = 0,09). Ratos jovens não-orquiectomizados apresentaram menor hiperalgesia mecânica que ratas jovens ooforectomizadas com reposição de 17beta-estradiol (p = 0,001), o mesmo não ocorreu entre machos e fêmeas jovens gonadectomizados sem reposição hormonal (p = 0,511). Ratas jovens ooforectomizadas sem reposição de 17beta-estradiol e ratas idosas mostraram diferença apenas no 7º dia (p = 0,002). Os resultados permitiram concluir que a reposição de 17beta-estradiol aumentou a hiperalgesia mecânica aos estímulos mecânicos após ligadura da quinta raiz lombar em ratas jovens ooforectomizadas, a hiperalgesia mecânica não diferiu entre os sexos em ratos jovens machos e fêmeas, a presença da gônada masculina diminuiu a hiperalgesia mecânica em ratos idosos e que houve diminuição da hiperalgesia mecânica em ratas idosas / Age and sex modify the pain experience in animals and humans. The effects of gonadal hormones have been studied in various experimental pain models, however, the effect of aging on pain perception needs further investigation. The effect of aging on neuropathic pain is not well established. In this study, we sought to determine how aging and gonadal hormones affect mechanical hyperalgesia using spinal nerve ligation as a neuropathic pain model in aged and young male and female Wistar rats. Animals were divided into seven groups: aged female, ovariectomized young females with 17beta-estradiol replacement, ovariectomized young females without 17beta-estradiol replacement, orchiectomized and non-orchiectomized aged and young males. Rats were tested for mechanical hyperalgesia in the plantar surface of the left hindpaw before nerve ligation and on days 7, 14, 21 and 28 after nerve ligation. All animals of all groups showed mechanical hyperalgesic behavior after spinal nerve ligation during entire period of 28 days. Hyperalgesia was independent of the sex of the animal, the presence or absence of gonadal hormones or age. There was no difference between non-orchiectomized aged and young males (p = 0.420), and between orchiectomized aged and young males (p = 0.560). There was difference between aged male rats with and without orchiectomy in days 14 (p = 0.038) and 28 (p = 0.002). Young ovariectomized female rats without 17beta-estradiol replacement had less hyperalgesia than young ovariectomized female rats with replacement (p = 0.001). There was no difference between aged orchiectomized male rats and old female rats (p = 0.09). Young non-orchiectomized male rats showed less mechanical hyperalgesia than young ovariectomized female rats with 17beta-estradiol replacement (p = 0.001), that did not occur between young orchiectomized males rats and young ovariectomized females rats without 17beta-estradiol replacement (p = 0.51). Young ovariectomized female rats without 17beta-estradiol replacement and old female rats showed differences only on day 7 (p = 0.002). These data suggest that estradiol presented a pronociceptive effect in young female rats in mechanical hyperalgesia in the neuropathic pain model, spinal nerve ligation, withdrawal threshold did not differ between sex, the presence of male gonadal hormones reduces mechanical hyperalgesia in old male rats and there is reduced mechanical hyperalgesia in aged female rats
157

Efeitos do estrogênio, raloxifeno e extrato de soja rico em genisteína sobre o osso de ratas adultas ovariectomizadas previamente androgenizadas / Effects of estrogen, raloxifene and genistein-rich soy extract on bone of ovariectomized adult female rats and previously androgenized

Fernanda Lopes de Freitas Condi 08 November 2011 (has links)
INTRODUÇÃO: O hipoestrogenismo pode determinar perda da massa mineral óssea, diminuindo a qualidade do osso. Assim, vários fármacos são ministrados para evitar esta perda, porém, podem determinar efeitos colaterais importantes. Portanto, questiona-se se o emprego do estrogênio associado a estas substâncias poderia minimizar os efeitos adversos e manteria a massa mineral óssea. Contudo, há poucas informações sobre os efeitos destas combinações. Esta pesquisa tem como objetivo avaliar a ação do estrogênio, raloxifeno e do extrato de soja rico em gensteína, isolado ou combinado no osso de ratas ovariectomizadas. MATERIAIS E MÉTODOS: No nono dia de nascimento, todas as ratas receberam propionato de testosterona (0,1 g/g). No sexto mês de idade, os animais do controle fisiológico foram identificados como GI e receberam apenas o veículo (propilenoglicol em 0,5 ml/dia) durante o experimento e os outros que receberam testosterona foram ovariectomizados e divididos aleatoriamente em seis grupos: GII veículo (controle castrado, n=6); GIII - estrogênio conjugados eqüinos (ECE, (50 g/Kg/dia, n=8); GIV raloxifeno (RAL, 0,75 mg/kg/dia, n=8); GV extrato de soja enriquecido com genisteína (ESG, 300 mg/kg/dia, n=7); GVI ECE + ESG (50 g/Kg/dia + 300 mg/kg/dia, n=7); GVII - ECE+RAL (50 g/Kg/dia + 0,75mg/kg/dia, n=6). Após três meses da cirurgia, os fármacos foram ministrados por 120 dias consecutivos. Posteriormente, os animais foram sacrificados sob anestesia, sendo retirada a tíbia esquerda para rotina histológica. Os cortes histológicos foram corados pela hematoxilina-eosina para avaliar a microarquitetura óssea. Foram feitos procedimentos imunoistoquímicos, de imunofluorescência e PCR para quantificar as principais proteínas ósseas estruturais (colágeno tipo I, osteocalcina, osteopontina e osteoprotegerina), bem como de seus respectivos RNA mensageiros. Os dados foram analisados pelos testes de ANOVA e Tukey. RESULTADOS: Todos os tratamentos determinaram aumento da quantidade de osso trabecular (p<0,05). As fibras totais de colágeno apresentaram-se aumentadas em todos os grupos tratados, exceto com o raloxifeno. Já as fibras finas de colágeno diminuíram apenas no grupo tratado com estrogênio. As frações de colágeno tipo I, mostraram-se aumentadas nos grupos tratados com estrogênio e sua asssociação com o raloxifeno. O colágeno tipo III esteve aumentado no grupo tratado com estrogênio em associação com extrato de soja rico em genisteína. Em relação às proteínas não colagenosas, a osteoprotegerina apresentou-se aumentada nos grupos tratados com estrogênio, suas associações e com o extrato de soja rico em genisteína. A osteopontina esteve diminuída em todos os grupos tratados e a osteocalcina mostrou-se aumentada apenas no grupo tratado com ralolxifeno, em comparação ao grupo castrado (p<0,05). Não houve diferença estatística significante do PCR em tempo real na análise dos transcritos entre os grupos estudados. CONCLUSÃO: A combinação de estrogênio com raloxifeno ou extrato de soja rico em genisteína não trouxe benefícios adicionais na qualidade do tecido ósseo, como ocorreu com esses fármacos isoladamente / INTRODUCTION: Hypoestrogenism can determine bone mineral loss, resulting in decreased bone quality. To prevent that process, several drugs are administered, which can lead, however, to important side effects. Therefore, it is questionable whether the use of estrogen associated with those substances could minimize the adverse effects and maintain bone mineral mass. There is little information on the effects of those compounds. This research aims to evaluate the action of unopposed estrogen or combined with raloxifene and genistein-rich soy extract on ovariectomized adult female rats. MATERIALS AND METHODS: On the ninth day of birth, rats received, testosterone propionate (0.1 mg / g). On the sixth month, animals in the physiological control were identified as GI and received only the vehicle (propylene glycol at 0.5 ml / day) during the experiment and the other which was administered testosterone underwent ovariectomy and divided randomly into six groups: GII - vehicle (control castrated, n = 6); GIII - conjugated equine estrogen (CEE, 50 mg / kg / day, n = 8); GIV - raloxifene (RAL, 0.75 mg / kg / day, n = 8) ; GV - soy extract enriched with genistein (ESG, 300 mg / kg / day, n = 7), GVI - ECE + ESG (50 mg / kg / day + 300 mg / kg / day, n = 7); GVII - ECE + RAL (50 mg / kg / day + 0.75mg/kg/day, n = 6).Three months after the surgery, drugs were consecutively administered for 120 days. Subsequently, the animals were sacrificed on anesthesia and their left tibiae were removed for routine histology. The histological sections were stained by hematoxylin-eosin to evaluate bone microarchitecture. Immunohistochemical, immunofluorescence and PCR procedures were performed to quantify the main structural bone proteins (type I collagen, osteocalcin, osteopontin, and osteoprotegerin) as well as their mRNA. The data were analyzed by ANOVA and Tukey test. RESULTS: All treatments led to increased amounts of trabecular bone (p <0.05). The total collagen fibers had to be enlarged in all treated groups, except with raloxifene. Already thin collagen fibers decreased only in the group treated with estrogen. The fractions of type I collagen, were increased in groups treated with estrogen and its asssociação with raloxifene. Type III collagen was increased in the group treated with estrogen in combination with soybean extract rich in genistein. Regarding the non-collagenous proteins, the increased osteoprotegerin presented in groups treated with estrogen, and their associations with soy extract rich in genistein. The osteopontin was decreased in all treated groups and osteocalcin was increased only in the treated group ralolxifeno, compared to the castrated group (p <0.05). There was no statistically significant difference from the real-time PCR analysis of transcribed between the groups. CONCLUSION: The combination of estrogen with raloxifene or genistein-rich soy extract was uncapable of bringing additional benefits to the quality of bone tissue as observed with those drugs alone
158

Long-term ovarian hormone deprivation alters functionalconnectivity, brain neurochemical profile and white matter integrityin the Tg2576 amyloid mouse model of Alzheimer’s disease

Kara, Firat, Belloy, Michael E., Voncken, Rick, Sarwari, Zahra, Garima, Yadav, Anckaerts, Cynthia, Langbeen, An, Leysen, Valerie, Shah, Disha, Jacobs, Jules, Hamaide, Julie, Bols, Peter, Audekerke, Johan Van, Daans, Jasmijn, Guglielmetti, Caroline, Kantarci, Kejal, Prevot, Vincent, Roßner, Steffen, Ponsaerts, Peter, Linden, Annemie Van der, Verhoye, Marleen 12 November 2024 (has links)
Premenopausal bilateral ovariectomy is considered to be one of the risk factors of Alzheimer's disease (AD). However, the underlying mechanisms remain unclear. Here, we aimed to investigate long-term neurological consequences of ovariectomy in a rodent AD model, TG2576 (TG), and wild-type mice (WT) that underwent an ovariectomy or sham-operation, using in vivo MRI biomarkers. An increase in osmoregulation and energy metabolism biomarkers in the hypothalamus, a decrease in white matter integrity, and a decrease in the resting-state functional connectivity was observed in ovariectomized TG mice compared to sham-operated TG mice. In addition, we observed an increase in functional connectivity in ovariectomized WT mice compared to sham-operated WT mice. Furthermore, genotype (TG vs. WT) effects on imaging markers and GFAP immunoreactivity levels were observed, but there was no effect of interaction (Genotype × Surgery) on amyloid-beta-and GFAP immunoreactivity levels. Taken together, our results indicated that both genotype and ovariectomy alters imaging biomarkers associated with AD.
159

Functional contributions of a sex-specific population of myelinated aortic baroreceptors in rat and their changes following ovariectomy

Santa Cruz Chavez, Grace C. January 2014 (has links)
Indiana University-Purdue University Indianapolis (IUPUI) / Gender differences in the basal function of autonomic cardiovascular control are well documented. Consistent baroreflex (BRx) studies suggest that women have higher tonic parasympathetic cardiac activation compared to men. Later in life and concomitant with menopause, a significant reduction in the capacity of the BRx in females increases their risk to develop hypertension, even exceeding that of age-matched males. Loss of sex hormones is but one factor. In female rats, we previously identified a distinct myelinated baroreceptor (BR) neuronal phenotype termed Ah-type, which exhibits functional dynamics and ionic currents that are a mix of those observed in barosensory afferents functionally identified as myelinated A-type or unmyelinated C-type. Interestingly, Ah-type afferents constitute nearly 50% of the total population of myelinated aortic BR in female but less than 2% in male rat. We hypothesized that an afferent basis for sexual dimorphism in BRx function exists. Specifically, we investigated the potential functional impact Ah-type afferents have upon the aortic BRx and what changes, if any, loss of sex hormones through ovariectomy brings upon such functions. We assessed electrophysiological and reflexogenic differences associated with the left aortic depressor nerve (ADN) from adult male, female, and ovariectomized female (OVX) Sprague-Dawley rats. Our results revealed sexually dimorphic conduction velocity (CV) profiles. A distinct, slower myelinated fiber volley was apparent in compound action potential (CAP) recordings from female aortic BR fibers, with an amplitude and CV not observed in males. Subsequent BRx studies demonstrated that females exhibited significantly greater BRx responses compared to males at myelinated-specific intensities. Ovariectomy induced an increased overall temporal dispersion in the CAP of OVX females that may have contributed to their attenuated BRx responses. Interestingly, the most significant changes in depressor dynamics occurred at electrical thresholds and frequencies most closely aligned with Ah-type BR fibers. Collectively, we provide evidence that, in females, two anatomically distinct myelinated afferent pathways contribute to the integrated BRx function, whereas in males only one exists. These functional differences may partly account for the enhanced control of blood pressure in females. Furthermore, Ah-type afferents may provide a neuromodulatory pathway uniquely associated with the hormonal regulation of BRx function.
160

The effect of exercise training on cholesterol and bile acid metabolism in ovariectomized rats

Farahnak, Zahra 11 1900 (has links)
Il existe un nombre grandissant de preuves au cours des dernières années que la diminution de la sécrétion des œstrogènes chez les animaux ovariectomisés (Ovx) et chez les femmes ménopausées conduit à une accumulation importante de triglycérides (TG) dans le foie. Cependant, les évidences de perturbations dans le métabolisme du cholestérol, en lien avec la diminution des œstrogènes, sont limitées à des observations de niveaux élevés de cholestérol total dans le plasma trouvés chez la femme ainsi que chez les animaux. En fait, l'impact de la suppression des œstrogènes sur le métabolisme du cholestérol dans le foie a reçu peu d'attention et montre quelques controverses. Par conséquent, les trois études présentées dans cette thèse ont été réalisées chez des rats Ovx, comme modèle animal de femmes post-ménopausées, afin de documenter les effets du retrait des œstrogènes sur les marqueurs moléculaires clés du métabolisme du cholestérol et des acides biliaires dans le foie et dans l'intestin et des effets potentiels de l’entraînement physique. Il a été en effet démontré que l'entraînement physique peut réduire le niveau plasmatique de cholestérol. Une amélioration du transport du cholestérol en périphérie vers le foie pour sa sécrétion subséquente dans la bile et pour son l'excrétion de l'organisme a été suggérée, bien que les mécanismes sous-jacents ne soient pas entièrement compris. Dans la première étude, nous avons démontré que les rattes Ovx nourris avec une diète standard et une diète standard + cholestérol avait un taux de cholestérol total dans le foie plus élevé (P <0,05) que les rattes avec une ovariectomie simulée (Sham) nourris avec ces deux derniers types de diète, tandis que la teneur en triglycérides du foie était plus élevée chez les rattes Ovx que chez les rattes Sham nourris avec une diète standard, une diète standard + cholestérol et aussi une diète riche en grasses + cholestérol. Étonnement, la diète standard + cholestérol a été associée à un niveau plasmatique plus faible (P <0,001) de cholestérol total et de triglycérides chez les rats Ovx que les rats Sham, ce qui suggère une diminution de la sécrétion de lipoprotéines à très basses densités (VLDL). Par conséquent, la transcription de plusieurs marqueurs clés de la synthèse des VLDL, y compris la microsomal triglyceride transfer Protein (MTP) et apoB-100, ont été réduites (P <0,05) chez les rattes Ovx par rapport aux rattes Sham nourris avec tous les trois types diètes et cette diminution de MTP et apoB-100 était plus prononcée chez les rats nourris avec la diète standard + cholestérol. Pour aller un peu plus loin, dans la deuxième étude, nous avons déterminé les effets de l'entraînement physique sur les marqueurs clés hépatiques de la voie farnesoid X receptor (FXR) - small heterodimer partner (SHP) - de cholestérol 7 alpha-hydroxylase (CYP7A1) (FXR-SHP-CYP7A1) impliquée dans la conversion de cholestérol en acides biliaires et de leur excrétion chez les rat Ovx nourris avec une diète standard + cholestérol. Notre groupe expérimental principal comprenait des rats Ovx nourris avec une diète riche en cholestérol (Ovx-Chol). Ce groupe a été comparé à un groupe de rats Ovx nourris avec une diète standard (Ovx-SD) et un groupe de rats Sham nourris avec une diète riche en cholestérol (Sham-Chol) pour observer, respectivement, l'effet de l'alimentation et l’effet du retrait de l'œstrogène. Les résultats de cette étude ont démontré que les niveaux de cholestérol total dans le plasma et dans le foie ne sont pas affectés par l'entraînement physique dans aucune des conditions expérimentales. L'alimentation en cholestérol a induit une accumulation plus importante chez les rats Sham et Ovx a mené à une accumulation du cholestérol dans le foie significativement plus élevée (P <0,001) que chez les rats Ovx-SD. Un effet principal d'entraînement physique (P <0,05) a été trouvée dans l’expression génique du SHP et de CYP7A1. Ce dernier gène est reconnu pour son implication majeure sur le contrôle de la biosynthèse des acides biliaires à partir du cholestérol. De plus, cette étude a montré que le récepteurs des LDL (LDL-R) et proprotein convertase subtilisin/kexin type 9 (PSCK9) au foie, qui sont impliqués dans l'absorption du cholestérol de la circulation, ne sont pas influencés par l’entraînement physique. Ces résultats suggèrent que l'entraînement physique module le métabolisme du cholestérol chez les animaux Ovx par un réglage positif de la formation des acides biliaires. Un nombre croissant de preuves récentes suggèrent que le transport inverse du cholestérol (RCT) peut également passer par une voie non-biliaire connue sous le nom « transintestinal cholesterol excretion » (TICE). En effet, le foie et l'intestin sont impliqués dans l'excrétion du cholestérol excédentaire du corps. Dans cette optique, dans la troisième étude, nous avons élargi nos recherches afin de déterminer si l'entraînement physique module l’expression des récepteurs de cholestérol de la membrane intestinale qui sont impliqués dans TICE chez les rats intacts et Ovx nourris avec une diète standard et une diète riche en cholestérol. Les résultats de cette étude ont montré que l'entraînement physique a augmenté (P <0,01) l’expression génique intestinale de LDL-R et de PCSK9 impliquées dans la captation du cholestérol intestinal de la circulation et de leur récepteur nucléaire, « sterol regulatory element-binding protein 2 » (SREBP2) (P <0,05) chez les rats Sham et Ovx par rapport aux rats sédentaires (Sed). D'autre part, l’expression des gènes hépatiques de LDL-R et de PCSK9 ont été supprimées (P <0,01) par l’alimentation riche en cholestérol, mais pas affectée par l'entraînement physique. L'expression du gène « flavin monooxygénase 3 » (FMO3), en tant que régulateur de l'équilibre du cholestérol dans le foie, a été diminuée de façon significative (P <0,01) par le cholestérol alimentaire chez les rats Sham et Ovx par rapport aux rats nourris avec la diète standard, mais demeure inchangée suite à l'entraînement physique et le retrait des œstrogènes. Un réglage positif de l'expression de gènes du LDL-R et PCSK9 intestinale par l'entraînement physique chez les rats intacts et Ovx suggère que l'entraînement physique peut contribuer à l’accroissement de l'élimination de cholestérol par la voie TICE. Dans l'ensemble, nos résultats indiquent qu'une combinaison d’une diète riche en cholestérol et un retrait des œstrogènes a mené à une diminution de l'expression des gènes des marqueurs essentiels de la synthèse de VLDL, ce qui implique une réduction de l'excrétion du cholestérol du foie. Il semble que la réduction de LDL-R hépatique pourrait être due à l'accumulation du cholestérol dans le foie. De plus, nos résultats ont présenté l’entraînement physique comme une intervention non pharmacologique appropriée pour stimuler l'excrétion du cholestérol excédentaire de l'organisme par le réglage positif des gènes impliqués dans la biosynthèse des acides biliaires dans le foie et les récepteurs intestinaux de cholestérol dans la voie TICE. / There has been accumulating evidence in recent years that the estrogen deficient state in ovariectomized (Ovx) animals and in postmenopausal women results in substantial liver triglyceride (TG) accumulation. However, evidence of disturbances in cholesterol metabolism in link with estrogen deficiency is limited to observations of higher plasma total cholesterol levels found in human as well as in animals. In fact, the impact of estrogen withdrawal on liver cholesterol metabolism has received little attention and shows some controversies. Therefore, the three studies presented in this thesis have been conducted in Ovx rats, as an animal model of post-menopausal women, to investigate the effects of estrogen withdrawal on key molecular markers of cholesterol and bile acid metabolism in liver and in transintestinal cholesterol excretion (TICE), and also to determine the potential role of exercise training as a positive alternative intervention. It has been shown that exercise training can improve plasma cholesterol levels. An enhanced transport of peripheral cholesterol toward the liver for subsequent secretion into bile and excretion from the body has been suggested; however, the underlying mechanism for this action is not fully understood. In the first study, we showed that estrogen withdrawal was associated with higher (P < 0.05) liver total cholesterol under the standard diet and the standard diet + cholesterol diet, while liver triglyceride (TG) content was higher in Ovx than in Sham rats in all three dietary conditions which are the standard diet, the standard diet + cholesterol and the high fat diet + cholesterol. Surprisingly, the standard diet + cholesterol was associated with lower (P < 0.001) plasma total cholesterol and TG levels in Ovx than in Sham rats, suggesting a decrease in very low-density lipoprotein (VLDL) secretion. Accordingly, several transcripts of key markers of VLDL synthesis including microsomal triglyceride transfer protein (MTP) and apoB-100 were decreased (P < 0.05) in Ovx compared to Sham rats under the three dietary conditions and even more so for MTP and apoB-100 when rats were fed the standard diet + cholesterol. To go one step further, in the second study we determined the effects of exercise training on hepatic key markers of farnesoid X receptor (FXR)-small heterodimer partner (SHP)-cholesterol 7 alpha-hydroxylase (CYP7A1) (FXR-SHP-CYP7A1) pathway, involved in cholesterol conversion into bile acid and excretion from the body, in Ovx cholesterol fed rats. Our main experimental group was Ovx rats fed a high cholesterol diet (Ovx-Chol) that was compared, on one hand, to a group of Ovx rats fed a standard diet (Ovx-SD) to observe the effects of the diet and, on the other hand, compared to a group of Sham operated rats fed the cholesterol diet (Sham-Chol) to observe the effect of estrogen withdrawal. Results of this study showed that plasma and liver total cholesterol levels were not affected by exercise training in any of the experimental conditions. Cholesterol feeding in both Sham and Ovx rats resulted in significantly (P<0.001) higher hepatic cholesterol accumulation than in Ovx-SD rats. A main effect of training (P< 0.05) was, however, found for transcripts of SHP and CYP7A1. The SHP and CYP7A1 transcripts were increased by training. These results suggest that exercise training through up-regulation of genes involved in bile acid formation may modulate cholesterol metabolism in Ovx animals. Finally, a recent growing body of evidence suggests that reverse cholesterol transport (RCT) can also proceed through a non-biliary pathway known as transintestinal cholesterol excretion (TICE). Indeed, both liver and intestine are involved in excretion of the excess cholesterol from the body. Based on this concept, we expanded our research to determine whether exercise training has an effect on intestinal membrane cholesterol receptors involved in TICE pathway in intact and Ovx rats fed a normal and a high cholesterol diet. Results of the third study showed that exercise training increased (P< 0.01) transcripts of intestinal LDL-R and PCSK9, which are involved in intestinal cholesterol uptake from circulation, and their nuclear transcription factor, intestinal sterol regulatory element-binding protein 2 (SREBP2) (P< 0.05) in both Sham and Ovx rats compared to rats remaining sedentary (Sed). On the other hand, hepatic LDL-R and PCSK9 gene expression was suppressed (P< 0.01) by cholesterol feeding but not affected by exercise training. Flavin monooxygenase 3 (FMO3) gene expression, as a cholesterol balance regulator in liver, was significantly decreased (P<0.01) by cholesterol feeding in both Sham and Ovx rats compared to rats were fed the SD diet but unchanged following exercise training and estrogen withdrawal. An up-regulation of intestinal gene expression of LDL-R and PCSK9 following voluntary wheel running in intact and Ovx rats suggests that exercise training may contribute to increased cholesterol elimination through the TICE pathway. Overall, our results indicate that a high cholesterol diet and ovariectomy combine to decrease the gene expression of key markers of VLDL synthesis suggesting a reduction in cholesterol excretion from the liver. Alternatively, it seems that reduced hepatic LDL-R transcript found in Ovx animals might be due to hepatic cholesterol accumulation. Moreover, our findings introduced exercise training as an appropriate non-pharmacological intervention to stimulate the excretion of the excess cholesterol from the body through upregulation of genes involved in bile acid biosynthesis in liver and intestinal basolateral cholesterol transporters in TICE.

Page generated in 0.0601 seconds